Bernard Horowitz
Corporate Officer/Principal at Horowitz Consultants LLC
Profile
Bernard Horowitz has been a Director of OMRIX Biopharmaceuticals, Inc. since February 2006.
Dr. Horowitz is a Director of Protein Therapeutics, Inc. Since January 2000, he has been a Principal of Horowitz Consultants LLC.
From 1995 to 1999, Dr. Horowitz served as Chief Scientific Officer, Executive Vice President and a Director of V.I.
Technologies, Inc. He served as a Scientific Consultant to the National Institutes of Health, the Food and Drug Administration, the National Hemophilia Foundation, the International Association of Biological Standardization and the World Health Organization.
He received a BS degree in Biology from the University of Chicago and a PhD in Biochemistry from Cornell University Medical College.
Bernard Horowitz active positions
| Companies | Position | Start |
|---|---|---|
| Horowitz Consultants LLC | Corporate Officer/Principal | 01/01/2000 |
Former positions of Bernard Horowitz
| Companies | Position | End |
|---|---|---|
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Director/Board Member | 30/12/2008 |
Biogentis, Inc.
 Biogentis, Inc. Pharmaceuticals: MajorHealth Technology Biogentis, Inc. is a biopharmaceutical company, which designs and develops healthcare solutions in the field of advanced wound care and regenerative medicines. The company provides three technology platforms: Dermalink, a fibronectin-based product for chronic wound healing, CyanoStrip, a wound closure system and a self-assembly tissue engineering technology. It is located in Montréal, Canada | Director/Board Member | 27/02/2008 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Chief Tech/Sci/R&D Officer | 01/01/1999 |
Protein Therapeutics, Inc.
 Protein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protein Therapeutics, Inc. developed pharmaceuticals. The company was headquartered in Tucson, AZ. | Director/Board Member | - |
Training of Bernard Horowitz
| The University of Chicago | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Biogentis, Inc.
Biogentis, Inc. Pharmaceuticals: MajorHealth Technology Biogentis, Inc. is a biopharmaceutical company, which designs and develops healthcare solutions in the field of advanced wound care and regenerative medicines. The company provides three technology platforms: Dermalink, a fibronectin-based product for chronic wound healing, CyanoStrip, a wound closure system and a self-assembly tissue engineering technology. It is located in Montréal, Canada | Health Technology |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
| Horowitz Consultants LLC | |
Protein Therapeutics, Inc.
Protein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protein Therapeutics, Inc. developed pharmaceuticals. The company was headquartered in Tucson, AZ. | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
- Stock Market
- Insiders
- Bernard Horowitz
